Archer Aviation Inc. (ACHR) insiders disclosed stock sales this week following the vesting of restricted stock units. The eVTOL company’s latest SEC filings show that the transactions took place between August 15 and August 18, with most of the activity linked to routine tax obligations rather than discretionary selling.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Breakdown of Insider Transactions
First is Chief People and Partnerships Officer, Tosha Perkins, who received more than 80,000 shares through vesting. She later sold 42,775 shares for about $420,000 to cover taxes and now holds close to 295,000 shares. Next is Interim Chief Financial Officer Priya Gupta, who gained nearly 20,000 shares, sold 10,224 shares for about $100,000, and retained around 147,000 shares. Chief Legal and Strategy Officer Eric Lentell sold 48,936 shares worth about $480,000 after vesting, leaving him with roughly 47,500 shares. He had also sold almost 96,000 shares in June, which signals a sharper reduction in his position compared with other executives.
Last is Chief Technology Officer Thomas Paul Muniz, who reported the largest transaction. He sold 86,133 shares for about $847,000, yet still holds around 1.3 million shares, making his stake the largest insider holding in the group by a wide margin.

In summary, the transactions reflect a consistent pattern. Executives received stock as part of their compensation packages and then sold a portion to settle tax liabilities. As a result, the sales should not be viewed as broad insider exits. The remaining holdings are still significant, with Muniz’s position underscoring continued exposure to Archer Aviation’s long-term performance.
Is Archer Aviation Stock a Good Buy?
Despite the stock’s speculative nature, Wall Street analysts remain optimistic about the company. Based on seven recent ratings, Archer Aviation boasts a “Moderate Buy” consensus with an average 12-month price target of $12.06. This implies a 30.66% upside from the current price.
